Your search returned 180 studies. (Get alerts for new studies):
- Pharmacokinetics/Pharmacodynamics of Albiglutide
Conditions: Diabetes Mellitus, Type 2
Location: Blue Ridge, Georgia
- Growth and Tolerance of Hypoallergenic Formulas
Conditions: Growth of Term Infants
Location: Dalton, Georgia
- Chronic Plaque Psoriasis (Ps) Registry
Conditions: Chronic Plaque Psoriasis
Location: Calhoun, Georgia
- Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypert
Conditions: Stage 1 Hypertension - Stage 2 Hypertension
Location: Blue Ridge, Georgia
- A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
Conditions: Type 2 Diabetes Mellitus - Chronic Kidney Disease
Location: Blue Ridge, Georgia
- A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional A
Conditions: Type 2 Diabetes
Location: Blue Ridge, Georgia
- A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and rLP2086 Vaccine When Given at the Same Time to Children Bet
Conditions: Vaccines - Meningococcal Vaccines
Location: Dalton, Georgia
- Laparoscopic Gastric Plication Operation for Patients With Severe or Morbid Obesity
Conditions: Morbid Obesity
Location: Dalton, Georgia
- Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain
Conditions: Low Back Pain
Location: Blue Ridge, Georgia
- Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide)
Conditions: Acute Coronary Syndrome
Location: Blue Ridge, Georgia
- Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma
Conditions: Sarcoma
Location: Chattanooga, Tennessee
- Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastom
Conditions: Brain and Central Nervous System Tumors
Location: Chattanooga, Tennessee
- Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallo
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Peritoneal Cavity Cancer
Location: Chattanooga, Tennessee
- Removal Versus Retention of Cerclage in Preterm Premature Rupture of Membranes (PPROM)
Conditions: Fetal Membranes, Premature Rupture
Location: Chattanooga, Tennessee
- Study to Assess Compliance With Long-Term Mercaptopurine Treatment in Young Patients With Acute Lymphoblastic Leukemia in Remission
Conditions: Leukemia
Location: Chattanooga, Tennessee
- Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors
Conditions: Kidney Cancer
Location: Chattanooga, Tennessee
- Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surge
Conditions: Kidney Cancer
Location: Chattanooga, Tennessee
- Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma
Conditions: Sarcoma
Location: Chattanooga, Tennessee
- Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia
Conditions: Cognitive/Functional Effects - Leukemia - Long-term Effects Secondary to Cancer Therapy in Children - Neurotoxicity - Psychosocial Effects of Cancer and Its Treatment
Location: Chattanooga, Tennessee
- Protocolized Care for Early Septic Shock
Conditions: Sepsis - Severe Sepsis - Septic Shock
Location: Nashville, Tennessee
- Prospective Aneurysm Trial: High Angle Aorfix™ Bifurcated Stent Graft
Conditions: Abdominal Aortic Aneurysms
Location: Chattanooga, Tennessee
- Tamoxifen or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer
Conditions: Breast Cancer
Location: Chattanooga, Tennessee
- Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
Conditions: Brain and Central Nervous System Tumors - Chronic Myeloproliferative Disorders - Leukemia - Long-term Effects Secondary to Cancer Therapy in Children - Lymphoma - Lymphoproliferative Disorder - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic S
Location: Chattanooga, Tennessee
- Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors
Conditions: Adrenocortical Carcinoma - Kidney Cancer - Liver Cancer - Neuroblastoma - Retinoblastoma - Sarcoma
Location: Chattanooga, Tennessee
- Isotretinoin With or Without Monoclonal Antibody, Interleukin-2, and Sargramostim Following Stem Cell Transplantation in Treating Patients With Neurob
Conditions: Neuroblastoma
Location: Chattanooga, Tennessee
- Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma
Conditions: Sarcoma
Location: Chattanooga, Tennessee
- FREEDOM: Following Rehabilitation, Economics and Everyday-Dialysis Outcome Measurements Study
Conditions: Kidney Failure, Chronic - End Stage Renal Disease, Requiring Dialysis
Location: Chattanooga, Tennessee
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
Conditions: Lung Cancer
Location: Chattanooga, Tennessee
- RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Conditions: Heart Failure - Anemia - Cardiovascular Disease - Ventricular Dysfunction - Congestive Heart Failure
Location: Chattanooga, Tennessee
- Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms Tumor
Conditions: Kidney Cancer - Metastatic Cancer
Location: Chattanooga, Tennessee
- Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia
Conditions: Leukemia
Location: Chattanooga, Tennessee
- A Pivotal Study of a Facet Replacement System to Treat Spinal Stenosis
Conditions: Lumbar Spinal Stenosis
Location: Chattanooga, Tennessee
- Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
Conditions: Leukemia - Lymphoma
Location: Chattanooga, Tennessee
- Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
Conditions: Arthritis, Rheumatoid
Location: Hixson, Tennessee
- Study of the Safety and Effectiveness of DIAM™ Spinal Stabilization System Versus Conservative Care
Conditions: Lumbar Degenerative Disc Disease
Location: Chattanooga, Tennessee
- A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis
Conditions: Atopic Dermatitis
Location: Chattanooga, Tennessee
- Condition of Approval Study
Conditions: Lumbar Spinal Stenosis
Location: Chattanooga, Tennessee
- Octreotide and Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor
Conditions: Neuroendocrine Carcinoma
Location: Chattanooga, Tennessee
- Rituximab, Lenalidomide, and Bortezomib in Mantle Cell Lymphoma
Conditions: Mantle Cell Lymphoma
Location: Chattanooga, Tennessee
- ChemoFx® PRO - A Post-Market Data Collection Study
Conditions: Ovarian Cancer - Fallopian Tube Cancer - Peritoneal Cancer - Uterine Neoplasms - Endometrial Cancer - Vaginal Cancer - Vulvar Cancer - Cervical Cancer - Lung Cancer - Carcinoid Tumor of Lung - Sarcoma of Lung - Mesothelioma - Colorectal Cancer
Location: Chattanooga, Tennessee
- ChemoFx® PRO - A Post-Market Data Collection Study
Conditions: Ovarian Cancer - Fallopian Tube Cancer - Peritoneal Cancer - Uterine Neoplasms - Endometrial Cancer - Vaginal Cancer - Vulvar Cancer - Cervical Cancer - Lung Cancer - Carcinoid Tumor of Lung - Sarcoma of Lung - Mesothelioma - Colorectal Cancer
Location: Chattanooga, Tennessee
- Chemotherapy and Radiation in Treating Patients With Stage 3 Non-Small Cell Lung Cancer
Conditions: Non Small Cell Lung Cancer
Location: Chattanooga, Tennessee
- Safety and Efficacy of Talactoferrin in Addition to Standard Chemotherapy in Patients With Non-small Cell Lung Cancer
Conditions: Non Small Cell Lung Cancer
Location: Chattanooga, Tennessee
- Efficacy and Safety of Nilotinib Patients With Newly Diagnosed CML - CP (Chronic Myelogenous Leukemia - Chronic Phase)
Conditions: Myelogenous Leukemia, Chronic
Location: Chattanooga, Tennessee
- Juvenile Idiopathic Arthritis (JIA) Registry
Conditions: Juvenile Idiopathic Arthritis
Location: Hixson, Tennessee
- Filgrastim-Mobilized Stem Cells for Transplantation Using Unrelated Donors
Conditions: Healthy
Location: Chattanooga, Tennessee
- Airway Pressure Release Ventilation (APRV) Compared to ARDSnet Ventilation
Conditions: Acute Lung Injury - Adult Respiratory Distress Syndrome - Kidney Injury
Location: Chattanooga, Tennessee
- Chronic Plaque Psoriasis (Ps) Registry
Conditions: Chronic Plaque Psoriasis
Location: Hixson, Tennessee
- Post-Approval Clinical Study of the Talent Thoracic Stent Graft to Treat Thoracic Aortic Aneurysms (THRIVE)
Conditions: Thoracic Aortic Aneurysms
Location: Chattanooga, Tennessee
- Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II End
Conditions: Endometrial Cancer - Fatigue - Neurotoxicity
Location: Chattanooga, Tennessee
- A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Conditions: Asthma
Location: Chattanooga, Tennessee
- PF-00299804 As A Single Oral Agent In Selected Patients With Adenocarcinoma Of The Lung
Conditions: Carcinoma, Non-small Cell
Location: Chattanooga, Tennessee
- Surveillance Program to Determine Product Specific Rates of Invasive Hib Disease
Conditions: Haemophilus Infections - Diphtheria - Tetanus - Polio - Pertussis
Location: Chattanooga, Tennessee
- Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women
Conditions: Breast Cancer
Location: Chattanooga, Tennessee
- Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke (DIAS-4)
Conditions: Stroke
Location: Chattanooga, Tennessee
- Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed By Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Ca
Conditions: Breast Cancer
Location: Chattanooga, Tennessee
- A Study of Ixabepilone as Second Line Therapy for Locally Advanced, Recurrent or Metastatic Endometrial Cancer
Conditions: Endometrial Cancer
Location: Chattanooga, Tennessee
- Trial of Poor Performance Status Patients (ToPPS)
Conditions: Non Small Cell Lung Cancer
Location: Chattanooga, Tennessee
- Collecting and Storing Samples of Bone Marrow and Blood From Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma
Conditions: Leukemia - Lymphoma
Location: Chattanooga, Tennessee
- Collecting Tumor Samples From Patients With Gynecological Tumors
Conditions: Cancer
Location: Chattanooga, Tennessee
- Study of Kidney Tumors in Young Patients
Conditions: Kidney Cancer - Nonneoplastic Condition
Location: Chattanooga, Tennessee
- Collecting and Storing Samples of Blood and Tumor Tissue From Patients With Osteosarcoma
Conditions: Sarcoma
Location: Chattanooga, Tennessee
- Collecting and Storing Biological Samples From Patients With Ewing Sarcoma
Conditions: Sarcoma
Location: Chattanooga, Tennessee
- Collecting and Storing Biological Samples From Young Patients With Hodgkin's Lymphoma
Conditions: Lymphoma
Location: Chattanooga, Tennessee
- Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma
Conditions: Neuroblastoma
Location: Chattanooga, Tennessee
- Preoperative Pemetrexed and Carboplatin for Select Stage IB, II, and III Non-Squamous Non-Small-Cell Lung Cancer
Conditions: Non Small Cell Lung Cancer
Location: Chattanooga, Tennessee
- Catheter Ablation Versus Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Conditions: Atrial Fibrillation - Arrhythmia - Stroke Prevention - Mortality
Location: Chattanooga, Tennessee
- Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma
Conditions: Chordoma - Desmoid Tumor - Sarcoma
Location: Chattanooga, Tennessee
- Collecting and Storing Blood and Brain Tumor Tissue Samples From Children With Brain Tumors
Conditions: Brain and Central Nervous System Tumors
Location: Chattanooga, Tennessee
- Study to Assess the Effectiveness of RCHOP With or Without VELCADE in Previously Untreated Non-Germinal Center B-Cell-like Diffuse Large B-Cell Lympho
Conditions: Non-Germinal B-Cell-like (GCB) Diffuse Large B-cell Lymphoma (DLBCL)
Location: Chattanooga, Tennessee
- Study of Patients With Advanced Non-Small Cell Lung Cancer
Conditions: Advanced Non-Small Cell Lung Cancer
Location: Chattanooga, Tennessee
- Study of Blood Samples From Newborns With Down Syndrome
Conditions: Leukemia
Location: Chattanooga, Tennessee
- Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Liver Cancer
Conditions: Liver Cancer
Location: Chattanooga, Tennessee
- Daily Everolimus in Combination With Trastuzumab and Vinorelbine in HER2/Neu Positive Women With Locally Advanced or Metastatic Breast Cancer
Conditions: HER2/Neu Over-expressing Locally Advanced Breast Cancer - Metastatic Breast Cancer
Location: Chattanooga, Tennessee
- Tibial Delayed Healing Pivotal Clinical Trial
Conditions: Tibial Delayed Healing
Location: Chattanooga, Tennessee
- Electronic Brachytherapy for the Treatment of NMSC
Conditions: Basal Cell Carcinoma - Squamous Cell Carcinoma
Location: Chattanooga, Tennessee
- Study of Safety and Tolerability of PCI-27483 in Patients With Pancreatic Cancer Patients Receiving Treatment With Gemcitabine
Conditions: Pancreatic Cancer - Ductal Adrenocarcinoma - Exocrine Pancreatic Cancer
Location: Chattanooga, Tennessee
- Prevention of Infection in Surgical Treatment of Closed Fractures: Comparative of Cefazolin vs Vancomycin
Conditions: Closed Fractures
Location: Chattanooga,, Tennessee
- Trial of Bendamustine, Bortezomib, and Rituximab in Patients With Previously Untreated Low Grade Lymphoma
Conditions: Lymphoma
Location: Chattanooga, Tennessee
- Low-Molecular-Weight Heparin (LMWH) for Deep Venous Thrombosis (DVT) Prophylaxis
Conditions: Deep Venous Thrombosis
Location: Chattanooga,, Tennessee
- INSIGHT Influenza Hospitalization Study (FLU 003)
Conditions: Influenza - (Influenza A and Subtypes Such as H3N2 and 2009 H1N1 or Influenza B)
Location: Chattanooga, Tennessee
- A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
Conditions: Ovarian Cancer - Non Small Cell Lung Cancer - Prostate Cancer - Colorectal Cancer - Gastric Cancer - Esophageal Cancer - Cancer of Head and Neck
Location: Chattanooga, Tennessee
- Safety and Efficacy of BGP-15 in Patients With Type 2 Diabetes Mellitus
Conditions: Diabetes Mellitus
Location: Athens, Tennessee
- Study of Denosumab as Adjuvant Treatment for Women With High Risk Early Breast Cancer Receiving Neoadjuvant or Adjuvant Therapy (D-CARE)
Conditions: Breast Cancer
Location: Chattanooga, Tennessee
- Trial of Gemcitabine/Carboplatin With or Without Iniparib (SAR240550) (a PARP1 Inhibitor) in Subjects With Previously Untreated Stage IV Squamous Non-
Conditions: Squamous Cell Lung Cancer
Location: Chattanooga, Tennessee
- Trial of Gemcitabine/Carboplatin With or Without Iniparib (SAR240550) (a PARP1 Inhibitor) in Subjects With Previously Untreated Stage IV Squamous Non-
Conditions: Squamous Cell Lung Cancer
Location: Chattanooga, Tennessee
- A Study for Patients With Recurrent or Metastatic Squamous Cell Head and Neck Cancer
Conditions: Head and Neck Neoplasms
Location: Chattanooga, Tennessee
- Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Conditions: Diarrhea Predominant Irritable Bowel Syndrome
Location: Chattanooga, Tennessee
- A Study of Trastuzumab Emtansine (T-DM1) Plus Pertuzumab/Pertuzumab Placebo Versus Trastuzumab [Herceptin] Plus a Taxane in Patients With Metastatic B
Conditions: Breast Cancer
Location: Chattanooga, Tennessee
- Efficacy and Safety Trial of Transcranial Laser Therapy Within 24 Hours From Stroke Onset (NEST-3)
Conditions: Acute Ischemic Stroke
Location: Chattanooga, Tennessee
- A Study to Determine if There is a Possible Association Between Nonarteritic Anterior Ischemic Optic Neuropathy (NAION) and Phosphodiesterase Type 5 (
Conditions: Nonarteritic Anterior Ischemic Optic Neuropathy
Location: Chattanooga, Tennessee
- A Study of Ramucirumab (IMC-1121B) Drug Product (DP) and Best Supportive Care (BSC) Versus Placebo and BSC as 2nd-Line Treatment in Patients With Hepa
Conditions: Hepatocellular Carcinoma
Location: Chattanooga, Tennessee
- Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Conditions: Leukemia
Location: Chattanooga, Tennessee
- Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide)
Conditions: Acute Coronary Syndrome
Location: Chattanooga, Tennessee
- Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With S
Conditions: Colorectal Cancer
Location: Chattanooga, Tennessee
- A Study of Chemotherapy and Ramucirumab vs. Chemotherapy Alone in Second Line Non-small Cell Lung Cancer Patients Who Received Prior First Line Platin
Conditions: Non Small Cell Lung Cancer
Location: Chattanooga, Tennessee
- Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED)
Conditions: Ovarian Cancer
Location: Chattanooga, Tennessee
- Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED)
Conditions: Ovarian Cancer
Location: Chattanooga, Tennessee
- A Study of Paclitaxel With or Without Ramucirumab in Metastatic Gastric Adenocarcinoma
Conditions: Gastric Cancer
Location: Chattanooga, Tennessee
- Study Evaluating the Safety and Efficacy of Onartuzumab (Metmab) And/Or Bevacizumab in Combination With Paclitaxel in Patients With Metastatic, Triple
Conditions: Breast Cancer
Location: Chattanooga, Tennessee
- Risk-Adapted Chemotherapy in Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia
Conditions: Leukemia
Location: Chattanooga, Tennessee
- Topical Lidocaine on the Cervix and Intra-Cervical Prior to Insertion of Intrauterine Devices
Conditions: Contraception
Location: Chattanooga, Tennessee
- Study Comparing Orteronel Plus Prednisone in Patients With Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer
Conditions: Prostate Cancer
Location: Chattanooga, Tennessee
- Study Comparing Orteronel Plus Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer
Conditions: Prostate Cancer
Location: Chattanooga, Tennessee
- A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional A
Conditions: Type 2 Diabetes
Location: Chattanooga, Tennessee
- A Study of LY2127399 in Patients With Systemic Lupus Erythematosus
Conditions: Systemic Lupus Erythematosus - Connective Tissue Disease - Autoimmune Disease
Location: Hixon, Tennessee
- Registry Study of Genesys HTA for Treatment of Menorrhagia
Conditions: Menorrhagia
Location: Chattanooga, Tennessee
- Belfort Dildy- Obstetrical Tamponade System Post-Marketing Surveillance Program
Conditions: Postpartum Uterine Bleeding
Location: Chattanooga, Tennessee
- A Phase 2, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of PF-00489791 In Patients With Type 2 Diabetes And Overt Nephropathy
Conditions: Diabetic Nephropathies
Location: Chattanooga, Tennessee
- TRINOVA-1: A Study of AMG 386 or Placebo, in Combination With Weekly Paclitaxel Chemotherapy, as Treatment for Ovarian Cancer, Primary Peritoneal Canc
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cancer
Location: Chattanooga, Tennessee
- Laparoscopic Gastric Plication Operation for Patients With Severe or Morbid Obesity
Conditions: Morbid Obesity
Location: Chattanooga, Tennessee
- Post-Myocardial Infarction Remodeling Prevention Therapy
Conditions: Acute Myocardial Infarction - Pacing Therapy - Cardiac Remodeling - Heart Failure
Location: Chattanooga, Tennessee
- Vinorelbine Ditartrate and Cyclophosphamide in Combination With Bevacizumab or Temsirolimus in Treating Patients With Recurrent or Refractory Rhabdomy
Conditions: Sarcoma
Location: Chattanooga, Tennessee
- Study of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma
Conditions: Metastatic Renal Cell Carcinoma
Location: Chattanooga, Tennessee
- FOLFOXIRI Plus Panitumumab Patients With Metastatic KRAS Wild-Type Colorectal Cancer With Liver Metastases Only
Conditions: Colorectal Cancer
Location: Chattanooga, Tennessee
- CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib
Conditions: Chronic Myelogenous Leukemia in Chronic Phase
Location: Chattanooga, Tennessee
- A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Conditions: Renal Cell Carcinoma - Cancer
Location: Chattanooga, Tennessee
- A Study of MK-3415, MK-6072, and MK-3415A in Participants Receiving Antibiotic Therapy for Clostridium Difficile Infection (MK-3415A-001 AM2)
Conditions: Clostridium Difficile Infection
Location: Chattanooga, Tennessee
- A Study of Ramucirumab in Patients With Gastric, Esophageal and Gastroesophageal Cancer
Conditions: Stomach Cancer - Esophageal Cancer
Location: Chattanooga, Tennessee
- Dose Response of 28 Days of Dosing of GSK962040 in Type I and II Diabetic Male and Female Subjects With Gastroparesis
Conditions: Gastroparesis
Location: Chattanooga, Tennessee
- Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer
Conditions: Breast Cancer
Location: Chattanooga, Tennessee
- Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery
Conditions: Melanoma (Skin)
Location: Chattanooga, Tennessee
- Study of HCD122 (Lucatumumab) and Bendamustine Combination Therapy in CD40+ Relapsed Follicular Lymphoma
Conditions: Follicular Lymphoma
Location: Chattanooga, Tennessee
- Efficacy and Safety Study of CAL-101 in Patients With Indolent B-Cell Non-Hodgkin Lymphoma
Conditions: Indolent Non-Hodgkin Lymphoma - Follicular Lymphoma - Small Lymphocytic Lymphoma - Lymphoplasmacytoid Lymphoma - Marginal Zone Lymphoma
Location: Chattanooga, Tennessee
- Trial Evaluating Xeomin® (incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Conditions: Cervical Dystonia - Blepharospasm
Location: Chattanooga, Tennessee
- A Study of Obinutuzumab (RO5072759) in Combination With CHOP Chemotherapy Versus MabThera/Rituxan (Rituximab) With CHOP in Patients With CD20-Positive
Conditions: Lymphoma, B-Cell
Location: Chattanooga, Tennessee
- A Clinical Study in Patients With Overactive Bladder With Leakage of Urine, to Find Out if the Medicine, Fesoterodine, Works in Those Patients Who Did
Conditions: Overactive Bladder - Bladder, Overactive - Overactive Urinary Bladder
Location: Chattanooga, Tennessee
- A Clinical Study in Patients With Overactive Bladder With Leakage of Urine, to Find Out if the Medicine, Fesoterodine, Works in Those Patients Who Did
Conditions: Overactive Bladder - Bladder, Overactive - Overactive Urinary Bladder
Location: Chattanooga, Tennessee
- Caspofungin Acetate or Fluconazole in Preventing Invasive Fungal Infections in Patients With Acute Myeloid Leukemia Who Are Undergoing Chemotherapy
Conditions: Fungal Infection - Leukemia - Neutropenia
Location: Chattanooga, Tennessee
- Cabazitaxel Versus Docetaxel Both With Prednisone in Patients With Metastatic Castration Resistant Prostate Cancer
Conditions: Prostate Cancer
Location: Chattanooga, Tennessee
- Cabazitaxel at 20 mg/m² Compared to 25 mg/m² With Prednisone for the Treatment of Metastatic Castration Resistant Prostate Cancer
Conditions: Prostate Cancer
Location: Chattanooga, Tennessee
- Study of Imprime PGG® in Combination With Cetuximab in Subjects With Recurrent or Progressive KRAS Wild Type Colorectal Cancer
Conditions: Colorectal Cancer
Location: Chattanooga, Tennessee
- Day Zero Urinary Catheter Removal in Gen Thoracic Surgery Patients
Conditions: Postoperative Retention of Urine - Postoperative Urinary Tract Infection
Location: Chattanooga, Tennessee
- BAY81-8973 Pediatric Safety and Efficacy Trial
Conditions: Haemophilia A
Location: Chattanooga, Tennessee
- A Study to Evaluate Pazopanib in Comparison to Pemetrexed in Maintenance Setting in Non-progressing Subjects With Metastatic Stage IVA and IVB Non-squ
Conditions: Lung Cancer, Small Cell
Location: Chattanooga, Tennessee
- Continuous Soluble Ferric Pyrophosphate (SFP) Iron Delivery Via Dialysate in Hemodialysis Patients
Conditions: Renal Failure Chronic Requiring Hemodialysis
Location: Chattanoga, Tennessee
- Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting
Conditions: Type 2 Diabetes Mellitus
Location: Chattanooga, Tennessee
- A Study of RoActemra/Actemra (Tocilizumab) in Comparison to Etanercept in Patients With Rheumatoid Arthritis and Cardiovascular Disease Risk Factors
Conditions: Cardiovascular Disease, Rheumatoid Arthritis
Location: Hixson, Tennessee
- Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Conditions: Renal Insufficiency, Chronic - Diabetes Mellitus, Type 2
Location: Chattanooga, Tennessee
- A Phase 2, Open-Label Study of Amuvatinib in Combination With Platinum-Etoposide Chemotherapy in Small Cell Lung Cancer
Conditions: Small Cell Lung Carcinoma
Location: Chattanooga, Tennessee
- A Study of Pertuzumab in Addition to Chemotherapy and Herceptin (Trastuzumab) as Adjuvant Therapy in Patients With HER2-Positive Primary Breast Cancer
Conditions: Breast Cancer
Location: Chattanooga, Tennessee
- National Marrow Donor Program Long-Term Donor Follow-Up
Conditions: Hematologic Neoplasms
Location: Chattanooga, Tennessee
- Bortezomib and Sorafenib Tosylate in Patients With Newly Diagnosed Acute Myeloid Leukemia With or Without Mutations
Conditions: Leukemia
Location: Chattanooga, Tennessee
- A Study to Assess Efficacy and Safety With VESIcare® to Improve Urinary Continence in Subjects After Robotic Assisted Radical Prostatectomy
Conditions: Urinary Incontinence
Location: Chattanooga, Tennessee
- A Phase II Study to Evaluate the Efficacy of TKI258 for the Treatment of Patients With FGFR2 Mutated or Wild-type Advanced and/or Metastatic Endometri
Conditions: Solid Tumors and Advanced Endometrial Cancer - Endometrial Cancer - Second-line Treatment - VEGF
Location: Chattanooga, Tennessee
- Acthar for Treatment of Proteinuria in Membranous Nephropathy Patients
Conditions: Proteinuria - Idiopathic Membranous Nephropathy
Location: Chattanooga, Tennessee
- A Study of LY2510924 and Sunitinib in Patients With Metastatic Renal Cell Carcinoma
Conditions: Metastatic Clear Cell Renal Cell Carcinoma
Location: Chattanooga, Tennessee
- A Double-blind Placebo-controlled Study to Evaluate Larazotide Acetate for the Treatment of Celiac Disease
Conditions: Celiac Disease
Location: Chattanooga, Tennessee
- A Prospective, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate Efficacy and Safety of Atrasentan, Including Thoracic Bioimpedance, in
Conditions: Diabetic Nephropathy - Chronic Kidney Disease
Location: Chattanooga, Tennessee
- Efficacy Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Kidney Injury
Conditions: Acute Kidney Injury
Location: Chattanooga, Tennessee
- Efficacy Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Kidney Injury
Conditions: Acute Kidney Injury
Location: Chattanooga, Tennessee
- Trial of Eribulin in Patients Who Do Not Achieve Pathologic Complete Response (pCR) Following Neoadjuvant Chemotherapy
Conditions: Metastatic Breast Cancer
Location: Chattanooga, Tennessee
- Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Conditions: Cognitive/Functional Effects - Leukemia - Neurotoxicity - Pain - Therapy-related Toxicity
Location: Chattanooga, Tennessee
- A Study of LY2523355 in Patients With Breast Cancer
Conditions: Metastatic Breast Cancer
Location: Chattanooga, Tennessee
- A Study of Trastuzumab Emtansine in Comparison With Treatment of Physician's Choice in Patients With HER2-Positive Breast Cancer Who Have Received at
Conditions: Breast Cancer
Location: Chattanooga, Tennessee
- A Study of Ramucirumab (IMC-1121B) in Combination With Eribulin Versus Eribulin Alone in Patients With Breast Cancer
Conditions: Breast Cancer
Location: Chattanooga, Tennessee
- The Plecanatide Chronic Idiopathic Constipation (CIC) Study
Conditions: Chronic Idiopathic Constipation
Location: Chattanooga, Tennessee
- Study of GDC-0941 or GDC-0980 With Fulvestrant Versus Fulvestrant in Advanced or Metastatic Breast Cancer in Patients Resistant to Aromatase Inhibitor
Conditions: Breast Cancer
Location: Chattanooga, Tennessee
- ReStore Thrombectomy Trial for Flow Restoration in Acute Ischemic Stroke Patients
Conditions: Ischemic Stroke
Location: Chattanooga, Tennessee
- A Study of LY2510924 in Patients With Extensive-Stage Small Cell Lung Carcinoma
Conditions: Extensive Stage Small Cell Lung Carcinoma
Location: Chattanooga, Tennessee
- Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled
Conditions: COPD - COPD Exacerbation - Lung Diseases - Respiratory Disorders - Pulmonary Disease - Chronic Obstructive Lung Diseases - Chronic Obstructive Airway Disease
Location: Chattanooga, Tennessee
- A Study of MM-121 With Paclitaxel in Platinum Resistant/ Refractory Advanced Ovarian Cancers
Conditions: Epithelial Ovarian Cancer - Fallopian Tube Cancer - Peritoneal Cancer
Location: Chattanooga, Tennessee
- A Study in Patients With Type I Diabetes Mellitus
Conditions: Diabetes Mellitus, Type 1
Location: Chattanooga, Tennessee
- A Study of Onartuzumab (MetMAb) in Combination With Tarceva (Erlotinib) in Patients With Met Diagnostic-Positive Non-Small Cell Lung Cancer Who Have R
Conditions: Non-Small Cell Lung Cancer
Location: Chattanooga, Tennessee
- A Phase 3 Extension Study to Investigate the Long-term Safety, Tolerability and Efficacy of PA21, a Phosphate Binder in Dialysis Patients
Conditions: Chronic Kidney Disease Requiring Chronic Dialysis
Location: Chattanooga, Tennessee
- A Study in Participants With Type 2 Diabetes Mellitus
Conditions: Diabetes Mellitus, Type 2
Location: Chattanooga, Tennessee
- A Phase 3 Study Comparing the Effects of Intravenous Epoetin Hospira and Epoetin Alfa (Amgen) in Patients With Chronic Renal Failure Requiring Hemodia
Conditions: Chronic Kidney Disease - Chronic Renal Failure
Location: Chattanooga, Tennessee
- Safety and Efficacy Study of Insulin Lispro Versus Insulin Aspart in Participants With Type 2 Diabetes on Insulin Pump Therapy
Conditions: Type 2 Diabetes Mellitus
Location: Chattanooga, Tennessee
- The BEACON Study (Breast Cancer Outcomes With NKTR-102)
Conditions: Locally Recurrent Breast Cancer - Metastatic Breast Cancer
Location: Chattanooga, Tennessee
- A Multi-Center Trial to Determine the Safety and Efficacy of LX1033 in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome
Conditions: Irritable Bowel Syndrome
Location: Chattanooga, Tennessee
- Treatment of Neuropathic Pain Associated With Diabetic Peripheral Neuropathy
Conditions: Diabetic Peripheral Neuropathy
Location: Chattanooga, Tennessee
- Observational Study to Evaluate the Simplified-STroke REhabilitation Assessment of Movement (S-STREAM) Scale in Subjects Who Have Experienced a Nonhem
Conditions: Nonhemorrhagic Ischemic Stroke - Motor Function
Location: Chattanooga, Tennessee
- A Safety Study of 3 Different Bowel Cleansing Preparations
Conditions: Colonoscopy - Bowel Preparation - Endoscopy
Location: Chattanooga, Tennessee
- Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes Mellitus on Basal Plus Mealtime Insulin
Conditions: Type 2 Diabetes Mellitus
Location: Chattanooga, Tennessee
- Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Basal Insulin With Oral Antidiabetic Therapy
Conditions: Type 2 Diabetes Mellitus
Location: Chattanooga, Tennessee
- Study To Understand Efficacy And Safety Of Investigational Agent (PF-04937319) Compared To Approved Agent (Glimepiride) In Patients With Diabetes On M
Conditions: Diabetes Mellitus, Type 2
Location: Chattanooga, Tennessee
- Study To Understand Efficacy And Safety Of Investigational Agent (PF-04937319) Compared To Approved Agent (Glimepiride) In Patients With Diabetes On M
Conditions: Diabetes Mellitus, Type 2
Location: Chattanooga, Tennessee
- A Trial Comparing the Efficacy, Patient-reported Outcomes and Safety of Insulin Degludec 200 U/mL vs Insulin Glargine in Subjects With Type 2 Diabetes
Conditions: Diabetes - Diabetes Mellitus, Type 2
Location: Chattanooga, Tennessee
- A Trial Investigating Safety and Efficacy of Treatment With BAY94-9027 in Severe Hemophilia A
Conditions: Hemophilia A
Location: Chattanooga, Tennessee
- Acthar for Treatment of Proteinuria in Diabetic Nephropathy Patients
Conditions: Diabetic Nephropathy
Location: Chattanooga, Tennessee
|